1. Product claims are treated as leads, not evidence.
Brand pages, ads, retailer pages, reviews, and trend signals can help identify what to investigate. They cannot prove efficacy.
Methodology
Our goal is simple: identify which cosmetic products and beauty devices have support from peer-reviewed and validated science, and where evidence is missing or overstated.
Brand pages, ads, retailer pages, reviews, and trend signals can help identify what to investigate. They cannot prove efficacy.
We prioritize peer-reviewed human data, DOI/PMID/registry identifiers, source freshness, retraction checks, and direct relevance to the product or device parameters.
Dermatology, epidemiology, biostatistics, chemistry, toxicology, device engineering, photobiology, claims, and legal experts review the claims relevant to their scope.
Recalls, warning letters, ambiguous drug/device claims, insufficient device specifications, or unsafe use patterns can block publication or require a restricted explainer.
A product can be popular and still receive a weak evidence grade. Ingredient-level evidence is not treated as finished-product proof.
Automated workflows draft evidence packets, but sensitive claims, strong verdicts, devices, and safety concerns require human review before publication.